Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system
- PMID: 19839712
- DOI: 10.3109/10611860903338462
Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system
Abstract
This article describes the preparation and characterization of solid lipid nanoparticles (SLNs) prepared with stearic acid (SLN-A) and a mixture of stearic acid and Compritol (SLN-B) as lipid matrix and poloxamer-188 as surfactant, using sodium taurocholate and ethanol as co-surfactant mixture, with a view to applying the SLN in topical ocular drug delivery. The SLNs were prepared by o/w microemulsion technique and characterized by time-resolved particle size analysis, polydispersity index, zeta(zeta)-potential, differential scanning calorimetry (DSC), IR-spectroscopy, and wide-angle X-ray diffractometry (WAXD). The results obtained in these studies were compared with SLN prepared with stearic acid alone. IR, WAXD, and DSC studies revealed low-crystalline SLN and were having positive zeta-potentials after three-months of storage. Results indicated mixed lipid-matrix produced SLN with low-crystallinity and smaller particle sizes and higher drug entrapment compared with SLN prepared with stearic acid alone, therefore SLN-B would be suitable for the preparation of nanosuspension. Nanosuspensions were subjected to rheological and physicochemical evaluation, in vitro drug release and ex vivo corneal permeation studies and their effect were evaluated on corneal hydration-level. SLN composed of stearic acid and compritol would prove to be a good ocular drug delivery system considering the smaller particle size, particle size stability, and physiologically tolerable components.
Similar articles
-
Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.Eur J Pharm Biopharm. 2007 Aug;67(1):48-57. doi: 10.1016/j.ejpb.2006.12.004. Epub 2006 Dec 16. Eur J Pharm Biopharm. 2007. PMID: 17276663
-
Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.Int J Pharm. 2007 Apr 4;334(1-2):179-89. doi: 10.1016/j.ijpharm.2006.10.032. Epub 2006 Oct 28. Int J Pharm. 2007. PMID: 17140752
-
Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.J Biomed Mater Res A. 2013 Jun;101(6):1813-27. doi: 10.1002/jbm.a.34453. Epub 2012 Dec 18. J Biomed Mater Res A. 2013. PMID: 23255511
-
Solid lipid nanoparticles for ocular drug delivery.Drug Deliv. 2010 Sep-Oct;17(7):467-89. doi: 10.3109/10717544.2010.483257. Drug Deliv. 2010. PMID: 20491540 Review.
-
Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.Drug Dev Ind Pharm. 2014 Dec;40(12):1565-75. doi: 10.3109/03639045.2014.909840. Epub 2014 Apr 25. Drug Dev Ind Pharm. 2014. PMID: 24766553 Review.
Cited by
-
Development and Evaluation of Chitosan Nanoparticles for Ocular Delivery of Tedizolid Phosphate.Molecules. 2022 Apr 4;27(7):2326. doi: 10.3390/molecules27072326. Molecules. 2022. PMID: 35408724 Free PMC article.
-
An approach to revolutionize cataract treatment by enhancing drug probing through intraocular cell line.Libyan J Med. 2018 Dec;13(1):1500347. doi: 10.1080/19932820.2018.1500347. Libyan J Med. 2018. PMID: 30045674 Free PMC article.
-
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.J Drug Deliv. 2012;2012:750891. doi: 10.1155/2012/750891. Epub 2011 Nov 24. J Drug Deliv. 2012. PMID: 22175030 Free PMC article.
-
Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds.Front Chem. 2022 Apr 13;10:850757. doi: 10.3389/fchem.2022.850757. eCollection 2022. Front Chem. 2022. PMID: 35494641 Free PMC article. Review.
-
Preparation of Ondansetron Hydrochloride-Loaded Nanostructured Lipid Carriers Using Solvent Injection Method for Enhancement of Pharmacokinetic Properties.Pharm Res. 2019 Jul 26;36(10):138. doi: 10.1007/s11095-019-2672-x. Pharm Res. 2019. PMID: 31350675
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources